Investigations

Search
Categories
Archives

Investment Monitoring From Robbins LLP

To ensure your financial investments are being managed honestly, enroll in Stock Watch, our free investment monitoring service for individual and institutional investors.

Investigation of Apache Corporation

Apache Corporation (APA) Misled Shareholders About the Viability of its Alpine High Resource Play On September 7, 2016, Apache announced the discovery of a new resource play in the Permian

Read More

Investigation of Ebix, Inc.

Ebix, Inc. (EBIX) Misled Shareholders About its Controls Over Financial Reporting and Oversight of its Gift Card Business  On February 19, 2021, after the market closed, Ebix revealed that its

Read More

Investigation of Apache Corporation

Apache Corporation (APA) Misled Shareholders About the Viability of its Alpine High Resource Play On September 7, 2016, Apache announced the discovery of a new resource play in the Permian

Read More

Investigation of Ebix, Inc.

Ebix, Inc. (EBIX) Misled Shareholders About its Controls Over Financial Reporting and Oversight of its Gift Card Business  On February 19, 2021, after the market closed, Ebix revealed that its

Read More

Investigation of Immunovant, Inc.

Immunovant, Inc. (IMVT) Misled Shareholders About the Viability of its Drug Candidate IMVT-1401 On September 29, 2019, Health Sciences Acquisitions Corporation (HSAC), then a special purpose acquisition company, entered into

Read More

Investigation of EHang Holdings Limited

EHang Holdings Limited (EH) Mischaracterized its Lead Product and Misled Shareholders Regarding its Financial Success          During the class period, EHang touted the viability of its aerial vehicle technology and

Read More

Investigation of QuantumScape Corporation

QuantumScape Corporation (QS) Misled Shareholders by Overstating the Viability, Power and Life of its Solid-State Battery         On November 27, 2020, QuantumScape went public via a business combination

Read More

Investigation of Immunovant, Inc.

Immunovant, Inc. (IMVT) Misled Shareholders About the Viability of its Drug Candidate IMVT-1401 On September 29, 2019, Health Sciences Acquisitions Corporation (HSAC), then a special purpose acquisition company, entered into

Read More

Investigation of EHang Holdings Limited

EHang Holdings Limited (EH) Mischaracterized its Lead Product and Misled Shareholders Regarding its Financial Success          During the class period, EHang touted the viability of its aerial vehicle technology and

Read More
Free!
Skip to content